rosiglitazone has been researched along with n-oleoylethanolamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elguero, J; Fresno, N; Goya, P; Macías-González, M; Pavón, FJ; Pérez-Fernández, R; Rodríguez de Fonseca, F; Romero-Cuevas, M; Sanz-Camacho, P; Torres-Zaguirre, A | 1 |
| Hashimoto, Y; Ishikawa, M; Makishima, M; Noguchi-Yachide, T; Okazaki, S; Shioi, R; Yamaguchi, T | 1 |
2 other study(ies) available for rosiglitazone and n-oleoylethanolamine
| Article | Year |
|---|---|
Novel Oxazolidinone-Based Peroxisome Proliferator Activated Receptor Agonists: Molecular Modeling, Synthesis, and Biological Evaluation.
Topics: Animals; Appetite Depressants; Dose-Response Relationship, Drug; Eating; Ligands; Models, Molecular; Molecular Conformation; Oxazoles; PPAR alpha; PPAR gamma; Rats; Structure-Activity Relationship | 2015 |
Structure-activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
Topics: Acetamides; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Molecular Structure; PPAR alpha; PPAR delta; Structure-Activity Relationship | 2016 |